AAAAAA

   
Results: 1-12 |
Results: 12
EFFECT OF INFLUENZA IMMUNIZATION ON IMMUNOLOGICAL AND VIROLOGICAL CHARACTERISTICS OF PEDIATRIC-PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: JACKSON CR VAVRO CL VALENTINE ME PENNINGTON KN LANIER ER KATZ SL DILIBERTI JH MCKINNEY RE WILFERT CM STCLAIR MH
Citation: Cr. Jackson et al., EFFECT OF INFLUENZA IMMUNIZATION ON IMMUNOLOGICAL AND VIROLOGICAL CHARACTERISTICS OF PEDIATRIC-PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Pediatric infectious disease journal, 16(2), 1997, pp. 200-204
1592U89, A NOVEL CARBOCYCLIC NUCLEOSIDE ANALOG WITH POTENT, SELECTIVEANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY
Authors: DALUGE SM GOOD SS FALETTO MB MILLER WH STCLAIR MH BOONE LR TISDALE M PARRY NR REARDON JE DORNSIFE RE AVERETT DR KRENITSKY TA
Citation: Sm. Daluge et al., 1592U89, A NOVEL CARBOCYCLIC NUCLEOSIDE ANALOG WITH POTENT, SELECTIVEANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1082-1093
IN-VITRO ANTIVIRAL ACTIVITY OF 141W94 (VX-478) IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS
Authors: STCLAIR MH MILLARD J ROONEY J TISDALE M PARRY N SADLER BM BLUM MR PAINTER G
Citation: Mh. Stclair et al., IN-VITRO ANTIVIRAL ACTIVITY OF 141W94 (VX-478) IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS, Antiviral research, 29(1), 1996, pp. 53-56
STAVUDINE (D4T, ZERIT(TM)) SENSITIVITIES IN CLINICAL HIV ISOLATES OBTAINED FROM A PEDIATRIC POPULATION
Authors: JACKSON CR VAVRO CL DILIBERTI JH VALENTINE ME MCKINNEY RE STCLAIR MH
Citation: Cr. Jackson et al., STAVUDINE (D4T, ZERIT(TM)) SENSITIVITIES IN CLINICAL HIV ISOLATES OBTAINED FROM A PEDIATRIC POPULATION, Pediatric research, 39(4), 1996, pp. 1029-1029
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG SUSCEPTIBILITY DURING ZIDOVUDINE (AZT) MONOTHERAPY COMPARED WITH AZT PLUS 2',3'-DIDEOXYINOSINE OR AZT PLUS 2',3'-DIDEOXYCYTIDINE COMBINATION THERAPY
Authors: LARDER BA KOHLI A BLOOR S KEMP SD HARRIGAN PR SCHOOLEY RT LANGE JMA PENNINGTON KN STCLAIR MH
Citation: Ba. Larder et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG SUSCEPTIBILITY DURING ZIDOVUDINE (AZT) MONOTHERAPY COMPARED WITH AZT PLUS 2',3'-DIDEOXYINOSINE OR AZT PLUS 2',3'-DIDEOXYCYTIDINE COMBINATION THERAPY, Journal of virology, 70(9), 1996, pp. 5922-5929
INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DERIVED FROM GP41 TRANSMEMBRANE PROTEIN - STRUCTURE-ACTIVITY STUDIES
Authors: KAZMIERSKI WM HAZEN RJ AULABAUGH A STCLAIR MH
Citation: Wm. Kazmierski et al., INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DERIVED FROM GP41 TRANSMEMBRANE PROTEIN - STRUCTURE-ACTIVITY STUDIES, Journal of medicinal chemistry, 39(14), 1996, pp. 2681-2689
IN-VITRO COMPARISON OF SELECTED TRIPLE-DRUG COMBINATIONS FOR SUPPRESSION OF HIV-1 REPLICATION - THE INTER-COMPANY COLLABORATION PROTOCOL
Authors: STCLAIR MH PENNINGTON KN ROONEY J BARRY DW
Citation: Mh. Stclair et al., IN-VITRO COMPARISON OF SELECTED TRIPLE-DRUG COMBINATIONS FOR SUPPRESSION OF HIV-1 REPLICATION - THE INTER-COMPANY COLLABORATION PROTOCOL, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 83-91
A CLINICAL AND MOLECULAR CHARACTERIZATION OF LONG-TERM SURVIVAL IN PEDIATRIC HIV PATIENTS
Authors: VAVRO CL JACKSON CR STCLAIR MH PENNINGTON KN LANIER ER VALENTINE ME MCKINNEY RE
Citation: Cl. Vavro et al., A CLINICAL AND MOLECULAR CHARACTERIZATION OF LONG-TERM SURVIVAL IN PEDIATRIC HIV PATIENTS, Journal of cellular biochemistry, 1995, pp. 245-245
ANTIVIRAL, METABOLIC, AND PHARMACOKINETIC PROPERTIES OF THE ISOMERIC DIDEOXYNUCLEOSIDE -AMINO-9H-PURIN-9-YL)TETRAHYDRO-2(S)-FURANMETHANOL
Authors: NAIR V STCLAIR MH REARDON JE KRASNY HC HAZEN RJ PAFF MT BOONE LR TISDALE M NAJERA I DORNSIFE RE AVERETT DR BORROTOESODA K YALE JL ZIMMERMAN TP RIDEOUT JL
Citation: V. Nair et al., ANTIVIRAL, METABOLIC, AND PHARMACOKINETIC PROPERTIES OF THE ISOMERIC DIDEOXYNUCLEOSIDE -AMINO-9H-PURIN-9-YL)TETRAHYDRO-2(S)-FURANMETHANOL, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 1993-1999
LONG-TERM SURVIVAL IN PEDIATRIC HIV
Authors: JACKSON CR VAVRO CL VALENTINE ME MCKINNEY RE STCLAIR MH
Citation: Cr. Jackson et al., LONG-TERM SURVIVAL IN PEDIATRIC HIV, Pediatric research, 37(4), 1995, pp. 178-178
5-CHLORO-2',3'-DIDEOXY-3'-FLUOROURIDINE (935U83), A SELECTIVE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AGENT WITH AN IMPROVED METABOLIC AND TOXICOLOGICAL PROFILE
Authors: DALUGE SM PURIFOY DJM SAVINA PM STCLAIR MH PARRY NR DEV IK NOVAK P AYERS KM REARDON JE ROBERTS GB FYFE JA BLUM MR AVERETT DR DORNSIFE RE DOMIN BA FERONE R LEWIS DA KRENITSKY TA
Citation: Sm. Daluge et al., 5-CHLORO-2',3'-DIDEOXY-3'-FLUOROURIDINE (935U83), A SELECTIVE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AGENT WITH AN IMPROVED METABOLIC AND TOXICOLOGICAL PROFILE, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1590-1603
ZIDOVUDINE RESISTANCE, SYNCYTIUM-INDUCING PHENOTYPE, AND HIV DISEASE PROGRESSION IN A CASE-CONTROL STUDY
Authors: STCLAIR MH HARTIGAN PM ANDREWS JC VAVRO CL SIMBERKOFF MS HAMILTON JD
Citation: Mh. Stclair et al., ZIDOVUDINE RESISTANCE, SYNCYTIUM-INDUCING PHENOTYPE, AND HIV DISEASE PROGRESSION IN A CASE-CONTROL STUDY, Journal of acquired immune deficiency syndromes, 6(8), 1993, pp. 891-897
Risultati: 1-12 |